logo
Twitter
Discord
Email
logo
Ardent Health Partners, Inc.

Ardent Health Partners, Inc.

NYSE•ARDT
CEO: Mr. Martin J. Bonick FACHE, M.H.A.
Sector: Healthcare
Industry: Medical - Care Facilities
Listing Date:
Ardent Health Partners, Inc. owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health Partners, Inc. is a subsidiary of EGI-AM Investments, L.L.C.
Contact Information
340 Seven Springs Way, Suite 100, Brentwood, TN, 37027, United States
615-296-3000
www.ardenthealth.com
Market Cap
$1.25B
P/E (TTM)
6.0
16.5
Dividend Yield
--
52W High
$17.34
52W Low
$8.28
52W Range
5%
Rank46Top 45.7%
3.9
F-Score
Modified Piotroski Analysis
Based on 8-year fundamentals
Weak • 3.9 / 9 points
Scoring Range (0-9)
8-9: Excellent Value
6-7: Strong Fundamentals
4-5: Average Quality
0-3: Weak Performance
Data Period: 2017-2024

Financial Dashboard

Q3 2025 Data

Revenue

$1.58B+8.76%
4-Quarter Trend

EPS

-$0.17-189.47%
4-Quarter Trend

FCF

$93.00M+91.02%
4-Quarter Trend

2025 Q3 Earnings Highlights

Key Highlights

Revenue Growth Strong Total revenue grew 8.8% to $1.58 B for the quarter; 9-month revenue increased 8.2% to $4.72 B.
Operating Cash Flow Improves Nine-month cash provided by operations reached $247.075 M, up $51.618 M from prior period, supporting liquidity.
Liquidity Position Solid Cash and equivalents totaled $609.441 M at period end; available liquidity stood at $903.8 M for needs.
Debt Refinancing Completed Term Loan B refinanced in September 2025, reducing applicable interest rate by 50 basis points immediately.

Risk Factors

Quarterly Net Loss Reported Net loss attributable to Ardent Health, Inc. was $(23.478) M for the quarter, reversing prior period income.
Professional Liability Reserves Surge $47.2 M professional liability reserve increase, driven by New Mexico adverse claim developments, impacted Q3 results.
Regulatory Environment Uncertainty OBBBA legislation introduces uncertainty regarding Medicaid funding mechanisms and potential federal payment reductions.
Labor Costs Remain High Competition and minimum wage increases in some markets create ongoing pressure on salaries and benefits expenses.

Outlook

Continue Acquisition Strategy Completed acquisition of 18 urgent care clinics in January 2025 for $27.5 M, planning further growth.
Manage Revenue Estimate Change Implemented new revenue accounting system, resulting in $42.6 M revenue decrease due to improved collectability estimates.
Capital Expenditures Planned Expect to finance future capital expenditures with internally generated funds and borrowed funds for modernization.
Debt Covenants Compliance Management believes compliance maintained with all financial covenants under the Ventas Master Lease as of September 30, 2025.

Peer Comparison

Revenue (TTM)

Ardent Health Partners, Inc.ARDT
$6.33B
+10.9%
Select Medical Holdings CorporationSEM
$5.37B
-23.0%
Acadia Healthcare Company, Inc.ACHC
$3.27B
+4.6%

Gross Margin (Latest Quarter)

Acadia Healthcare Company, Inc.ACHC
96.7%
+72.8pp
Ardent Health Partners, Inc.ARDT
57.1%
+13.2pp
National HealthCare CorporationNHC
39.8%
+1.6pp

Key Metrics

Symbol
Market Cap
P/E (TTM)
ROE (TTM)
Debt to Assets
BKD$2.43B-7.8-267.9%19.2%
NHC$2.13B20.310.5%11.0%
ADUS$2.11B24.58.5%3.6%

Long-Term Trends

Last 4 Quarters
Revenue
Net Income
Operating Cash Flow
4Q Revenue CAGR
-0.6%
Flat Growth
4Q Net Income CAGR
N/M
Profitability Shift
Cash Flow Stability
75%
Volatile Cash Flow

Research & Insights

Next earnings:Feb 25, 2026
|
EPS:$0.35
|
Revenue:-
Reports
All Years

  • Form 10-Q - Q3 2025

    Period End: Sep 30, 2025|Filed: Nov 14, 2025|
    Revenue: $1.58B+8.8%
    |
    EPS: $-0.17-189.5%
    Miss

  • Form 10-Q - Q2 2025

    Period End: Jun 30, 2025|Filed: Aug 6, 2025|
    Revenue: $1.65B+11.9%
    |
    EPS: $0.52+73.3%
    Beat

  • Form 10-Q - Q1 2025

    Period End: Mar 31, 2025|Filed: May 7, 2025|
    Revenue: $1.50B+4.0%
    |
    EPS: $0.30+57.9%
    Beat

  • Form 10-K - FY 2024

    Period End: Dec 31, 2024|Filed: Feb 27, 2025|
    Revenue: $5.97B+10.3%
    |
    EPS: $1.59+354.3%
    Beat

  • Form 10-Q - Q3 2024

    Period End: Sep 30, 2024|Filed: Nov 7, 2024|
    Revenue: $1.45B+5.2%
    |
    EPS: $0.19+26.7%
    Miss

  • Form 10-Q - Q2 2024

    Period End: Jun 30, 2024|Filed: Aug 14, 2024|
    Revenue: $1.47B+7.5%
    |
    EPS: $0.30+30.4%
    Meet